from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0492c/-

LFCtreatmentdescriptionclass of inhibitor

-0.870

Amikacinug/mL Amikacintranslation

-1.296

Cap5-10ug/mL Capreomycintranslation

0.494

Rox10-50 ug/mL Roxithromycintranslation

-0.819

SM2-5 ug/mL Streptomycintranslation

-1.206

Tet5-10 ug/mL Tetracyclinetranslation

0.891

Rif0.2-5ug/mL Rifampicintranscription

0.284

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.934

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.230

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.320

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.654

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.148

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.133

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.730

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.433

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.294

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.609

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.089

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.341

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.056

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.486

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.529

Nigericin50 uM Nigericinrespiration

-0.292

TRC10-150 ug/mL Triclosanrespiration

-1.925

TRZ10-25 ug/mL Thioridazinerespiration

-0.803

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.496

menadione6-10 ug/mL Menadionerespiration

0.297

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.162

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.567

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.119

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.682

NRP_1Non-replicating persistence stage 1dosRassociated

-0.442

Amp0.2mg/mL AmpicillincellWall

-0.160

Cephalexin20-100 ug/mL CephalexincellWall

0.181

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.561

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.115

EMB10-20 ug/mL EthambutolcellWall

-0.819

Eta12-40 ug/mL EthionamidecellWall

-0.537

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.445

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.384

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.223

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.944

BZA0.12 mg/mL BenzamidearomaticAmides

0.886

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.461

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.147

H2O24 mM hydrogen peroxideDNAdamaging

0.299

Levo10 ug/mL LevofloxacinDNAdamaging

0.385

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.021

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.323

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.664

UVUV-irradiationDNAdamaging

-0.008

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.007

Antimycin12.5-50 ug/mL Antimycin A?

-0.374

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.283

PA_110-50 ug/mL Antitubercular compound PA-1?

0.731

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.199

PA8240.2-2 ug/mL PA-824?

0.185

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.442

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.361

Verapamil50 uM Verapamil?

-0.526

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.405

methoxatin10-20 ug/mL Methoxatin?